Societies

OncoDaily

News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

August, 2025

Societies

Just presented at ASCO24: IMROZ results by C. Ola Landgren – ASCO

Photo taken from ASCO/X

Jun 4, 2024, 16:31

Just presented at ASCO24: IMROZ results by C. Ola Landgren – ASCO

ASCO shared a post on X:

“Just presented at American Society of Clinical Oncology 2024 (ASCO24), IMROZ results- lsatuximab, bortezomib, lenalidomide, and dexamethasone (Isa-VRd) significantly improved Progression-Free Survival (PFS) in patients with transplant-ineligible, newly diagnosed Multiple Myeloma versus Velcade, Revlimid and dexamethasone (VRd) with no new safety concerns.”

Additional information
Source: ASCO/X

ASCO ASCO24 C. Ola Landgren cancer dexamethasone IMROZ Isatuximab multiple myeloma OncoDaily Oncology progression-free survival Revlimid Velcade

'

Kirsty Duncan։ Thirty-two Months Into Fighting Cancer...

'

World’s Nicest Judge Frank Caprio Dies at 88 After Brave Battle with Pancreatic Cancer

'

IMvigor011 Trial Reports ctDNA as Predictor of Response to Adjuvant Atezolizumab in Bladder Cancer

'

Ruben Mesa is Starting a New Position as President of Cancer National Service Line at Advocate Health

'

Patrick Soon-Shiong: 30 Years and $3B Toward a Universal Cancer Fighter

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023

Opinion

Aug 21, 2025, 12:03

UICC Enhances Cancer Care with Nutrition and Psycho-Oncology Support

Voices

Aug 21, 2025, 11:40

FDA has Granted Full Market Approval for Papzimeos - NIH

Insight

Aug 21, 2025, 11:16

Kefah Mokbel: TAD Proven Safe with Effective Long-Term Outcomes for Breast Cancer Patients

Voices

Aug 21, 2025, 11:15

Kirsty Duncan։ Thirty-two Months Into Fighting Cancer...

OncoDaily Pulse

Aug 21, 2025, 10:23

Archana Ajmera: Meet the Experts of VIRO 2025

OncoDaily Pulse

Aug 21, 2025, 10:08

Yüksel Ürün: Meet the Experts of VIRO 2025

Voices

Aug 21, 2025, 09:46

Pratiti Bandopadhayay: Urgent Need to Sustain Funding for Pediatric Brain Tumor Trials

Voices

Aug 21, 2025, 09:30

Jana Ellegast: Inflammatory Signaling in the Pathogenesis of AML

Insight

Aug 21, 2025, 09:02

Humaid Al-Shamsi: Outcomes of HSCT from Matched Related Donors in Pediatric Patients

Celebrities

Aug 21, 2025, 08:40

World’s Nicest Judge Frank Caprio Dies at 88 After Brave Battle with Pancreatic Cancer

Insight

Aug 21, 2025, 08:17

Weight Loss Trial Reports Success for Breast Cancer Patients at One Year Mark

Science

Aug 21, 2025, 06:29

Moazzam Shahzad: The Impact of MRD Status after Matched Donor alloHCT in AML